Related Experiment Videos
[Endometrial carcinoma without myometrial invasion]
N Takeshima1, S Umezawa, T Yamawaki
1Department of Gynecology, Cancer Institute Hospital, Tokyo.
Nihon Sanka Fujinka Gakkai Zasshi
|June 1, 1995
Summary
Even without myometrial invasion, endometrial cancer can recur. This study highlights the necessity of lymphadenectomy and vigilant follow-up for all endometrial cancer patients, including early-stage, low-grade cases.
Area of Science:
- Gynecologic Oncology
- Pathology
- Surgical Oncology
Context:
- Endometrial cancer management
- Hysterectomy outcomes
- Pathological staging
Purpose:
- Analyze recurrence patterns in endometrial cancer patients without myometrial invasion
- Evaluate the role of lymphadenectomy and peritoneal cytology
- Determine optimal follow-up strategies
Summary:
- A retrospective analysis of 92 endometrial cancer patients without myometrial invasion revealed a 2.2% recurrence rate, primarily local.
- Pelvic lymphadenectomy identified metastasis in 2.9% of cases (G1 adenocarcinoma), yet no subsequent relapse occurred.
- Positive peritoneal cytology was observed in 13.4%, with most cases showing no recurrence, underscoring the need for comprehensive staging.
Impact:
- Suggests lymphadenectomy and meticulous follow-up are crucial for all endometrial cancer patients, irrespective of myometrial invasion or grade.
- Informs clinical decision-making regarding surgical staging and adjuvant therapy for early-stage endometrial cancer.
- Contributes to understanding the prognostic significance of peritoneal cytology and lymph node status in low-risk endometrial cancer.